Experimental drug may disrupt immune circuits in pneumonia

A drug that blocks calcium release-activated calcium (CRAC) channels may help interrupt harmful immune cell interactions that drive severe viral pneumonia, according to a new study published in The Journal of Clinical Investigation. The findings provide new insight into how the experimental drug Auxora works and may inform future precision medicine approaches to treating pneumonia, said the study's senior author, G. R. Scott Budinger, MD, chief of Pulmonary and Critical Care in the Department of Medicine.

≈